Ver registro no DEDALUS
Exportar registro bibliográfico



The cognitive effects of opioids in cancer: a systematic review (2009)

  • Authors:
  • USP Schools: EE
  • DOI: 10.1007/s00520-008-0497-y
  • Language: Inglês
  • Imprenta:
  • Source:
  • Acesso online ao documento

    DOI or search this record in
    Informações sobre o DOI: 10.1007/s00520-008-0497-y (Fonte: oaDOI API)
    • Este periódico é de assinatura
    • Este artigo NÃO é de acesso aberto
    Informações sobre o Citescore
  • Título: Supportive Care in Cancer

    ISSN: 0941-4355

    Citescore - 2017: 2.55

    SJR - 2017: 1.297

    SNIP - 2017: 1.147

  • Exemplares físicos disponíveis nas Bibliotecas da USP
    BibliotecaCód. de barrasNúm. de chamada
    EE2314041-10PIMENTA, C. A. de M. doc 108
    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      KURITA, Geana Paula; LUNDORFF, Lena; PIMENTA, Cibele Andrucioli de Mattos; SJOGREN, Per. The cognitive effects of opioids in cancer: a systematic review. Supportive Care in Cancer, Heidelberg, v. 17, n. Ja 2009, p. 11-21, 2009. DOI: 10.1007/s00520-008-0497-y.
    • APA

      Kurita, G. P., Lundorff, L., Pimenta, C. A. de M., & Sjogren, P. (2009). The cognitive effects of opioids in cancer: a systematic review. Supportive Care in Cancer, 17( Ja 2009), 11-21. doi:10.1007/s00520-008-0497-y
    • NLM

      Kurita GP, Lundorff L, Pimenta CA de M, Sjogren P. The cognitive effects of opioids in cancer: a systematic review. Supportive Care in Cancer. 2009 ; 17( Ja 2009): 11-21.
    • Vancouver

      Kurita GP, Lundorff L, Pimenta CA de M, Sjogren P. The cognitive effects of opioids in cancer: a systematic review. Supportive Care in Cancer. 2009 ; 17( Ja 2009): 11-21.

    Referências citadas na obra
    Airaksinen E, Larsson M, Lundberg I, Forsel L (2004) Cognitive functions in depressive disorders: evidence from a population-based study. Psychol Med 34(1):83–91. doi: 10.1017/S0033291703008559
    Airaksinen E, Larsson M, Forsell Y (2005) Neuropsychological functions in anxiety disorders in population-based samples: evidence of episodic memory dysfunction. J Psychiatr Res 39(2):207–214. doi: 10.1016/j.jpsychires.2004.06.001
    Austin MP, Mitchell P, Goodwin GM (2001) Cognitive deficits in depression: possible implications for functional neuropathology. Br J Psychiatry 178:200–206. doi: 10.1192/bjp.178.3.200
    Banning A, Sjøgren P (1990) Cerebral effects of long-term oral opioids in cancer patients measured by continuous reaction time. Clin J Pain 6:91–95. doi: 10.1097/00002508-199006000-00005
    Banning A, Sjøgren P, Kaiser F (1992) Reaction time in cancer patients receiving peripherally acting analgesics alone or in combination with opioids. Acta Anaesthesiol Scand 36:480–482
    Barsevick AM, Whitmer K, Nail L, Beck SL, Dudley WN (2006) Symptom cluster research: conceptual, design, measurement, and analysis issue. J Pain Symptom Manage 31(1):85–95. doi: 10.1016/j.jpainsymman.2005.05.015
    Barsevick AM (2007) The concept of symptom cluster. Semin Oncol Nurs 23(2):89–98. doi: 10.1016/j.soncn.2007.01.009
    Bender CM, Sereika SM, Berga SL, Vogel VG, Brufsky AM, Paraska KK et al (2006) Cognitive impairment associated with adjuvant therapy in breast cancer. Psychooncology 15:422–430. doi: 10.1002/pon.964
    Bruera E, Macmillan K, Hanson J, MacDonald RN (1989) The cognitive effects of the administration and narcotic analgesics in patients with cancer pain. Pain 39:13–16. doi: 10.1016/0304-3959(89)90169-3
    Chapman SL, Byas-Smith MG, Reed BA (2002) Effects of intermediate and long-term use of opioids on cognition in patients with chronic pain. Clin J Pain 18:S83–S90. doi: 10.1097/00002508-200207001-00010
    Christrup LL, Sjøgren P, Jensen N-H, Banning AM, Elbæk K, Ersbøll AK (1999) Steady-state kinetics and dynamics of morphine in cancer patients: is sedation related to the absorption rate of morphine? J Pain Symptom Manage 18:164–173. doi: 10.1016/S0885-3924(99)00068-8
    Clemons M, Regnard C, Appleton T (1996) Alertness, cognition and morphine in patients with advanced cancer. Cancer Treat Rev 22:451–468. doi: 10.1016/S0305-7372(96)90026-2
    de Stoutz ND, Bruera E, Suarez-Almazor M (1995) Opioid rotation for toxicity reduction in terminal cancer patients. J Pain Symptom Manage 10:378–384. doi: 10.1016/0885-3924(95)90924-C
    Derogatis LR, Morrow GR, Fetting J, Penman D, Piasetsky S, Schmale AM et al (1983) The prevalence of psychiatric disorders among cancer patients. JAMA 249:751–757. doi: 10.1001/jama.249.6.751
    Dodd MJ, Janson S, Facione N, Faucett J, Froelicher ES, Humphreys J et al (2001) Advancing the science of symptom management. J Adv Nurs 33(5):668–676. doi: 10.1046/j.1365-2648.2001.01697.x
    Elsass P (1986) Continuous reaction times in cerebral dysfunction. Acta Neurol Scand 73:1–22
    Ersek M, Cherrier MM, Overman SS, Irving GA (2004) The cognitive effects of opioids. Pain Manag Nurs 5(2):75–93. doi: 10.1016/j.pmn.2003.11.002
    Falleti MG, Sanfilippo A, Maruff P, Weih L, Phillips KA (2005) The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: a meta-analysis of the current literature. Brain Cogn 59(1):60–70. doi: 10.1016/j.bandc.2005.05.001
    Fletcher RH, Fletcher SW, Wagner EH (2005) Clinical epidemiology: the essentials, 4th edn. Lippincott Williams & Wilkins, Baltimore
    Gronwall D, Wrightson P (1974) Delayed recovery of intellectual function after minor head injury. Lancet 304(7881):605–609. doi: 10.1016/S0140-6736(74)91939-4
    Jansen CE, Miaskowski C, Dodd M, Dowling G, Kramer J (2005) A metaanalysis of studies of the effects of cancer chemotherapy on various domains of cognitive function. Cancer 104(10):2222–2233. doi: 10.1002/cncr.21469
    Jensen AR, Rohwer WD Jr (1966) The stroop color-word test: a review. Acta Psychol (Amst) 25:36–93. doi: 10.1016/0001-6918(66)90004-7
    Kamboj SK, Tookman A, Jones L, Curran HV (2005) The effects of immediate-release morphine on cognitive functioning in patients receiving chronic opioid therapy in palliative care. Pain 117:388–395. doi: 10.1016/j.pain.2005.06.022
    Klepstad P, Hilton P, Moen, Fougner B, Borchgrevink PC, Kaasa S (2002) Self-reports are not related to objective assessment of cognitive function and sedation in patients with cancer pain admitted to a palliative care unit. Palliat Med 16:513–519. doi: 10.1191/0269216302pm587oa
    Klepstad P, Borchgrevink PC, Dale O, Zahlsen K, Aamo T, Fayers P et al (2003) Routine drug monitoring of serum concentrations of morphine, morphine-3-glucuronide and morphine-6-glucuronide do not predict clinical observations in cancer patients. Palliat Med 17:679–687
    Lawlor PG (2002) The panorama of opioid-related cognitive dysfunction in patients with cancer. Cancer 94(6):1836–1853. doi: 10.1002/cncr.10389
    Lawlor PG, Gagnon B, Mancini IL, Pereira JL, Hanson J, Suarez-Almazor ME et al (2000) Occurrence, causes, and outcome of delirium in advanced cancer patients: a prospective study. Arch Intern Med 160:786–794. doi: 10.1001/archinte.160.6.786
    Levine PM, Silberfarb PM, Lipowski ZJ (1978) Mental disorders in cancer patients a study of 100 psychiatric referrals. Cancer 43:1385–1391. doi: 10.1002/1097-0142(197809)42:3<1385::AID-CNCR2820420349>3.0.CO;2-0
    Lezak MD (1995) Neurobehavioral variables and diagnostic issues. In: Lezak MD (ed) Neuropsychological assessment, 3rd ed. Oxford University Press, New York, pp 277–331
    Lorenz J, Beck H, Bromm B (1997) Cognitive performance, mood and experimental pain before and during morphine-induced analgesia in patients with chronic non-malignant pain. Pain 73:369–375. doi: 10.1016/S0304-3959(97)00123-1
    Massie MJ, Holland J, Glass E (1983) Delirium in terminally ill cancer patients. Am J Psychiatry 140:1048–1050
    McCracken LM, Iverson GL (2001) Predicting complaints of impaired cognitive functioning in patients with chronic pain. J Pain Symptom Manage 21(5):392–396. doi: 10.1016/S0885-3924(01)00267-6
    McNamara P (2002) Opioid switching from morphine to transdermal fentanyl for toxicity reduction in palliative care. Palliat Med 16:425–434. doi: 10.1191/0269216302pm536oa
    Mercadante S, Casuccio A, Fulfaro F, Groff L, Boffi R, Villari P et al (2001) Switching from morphine to methadone to improve analgesia and tolerability in cancer patients: a prospective study. J Clin Oncol 19:2898–2904
    Meyers CA, Wefel JS (2003) The use of the Mini-mental State Examination to assess cognitive functioning in cancer trails: no ifs, ands, buts, or sensitivity. J Clin Oncol 21:3557–3558. doi: 10.1200/JCO.2003.07.080
    Pereira J, Hanson J, Bruera E (1997) The frequency and clinical course of cognitive impairment in patients with terminal cancer. Cancer 79:835–842. doi:10.1002/(SICI)1097-0142(19970215)79:4<835::AID-CNCR21>3.0.CO;2-#
    Peters M (1976) Prolonged practice of a simple motor task by preferred and non-preferred hands. Percept Mot Skills 42:447–450
    Phillips B, Ball C, Sackett D, Badenoch D, Straus S, Haynes B, et al (1998) Oxford centre for evidence-based medicine levels of evidence. . Accessed 11 January 2007
    Reitan RM (1958) Validity of the trail making test as an indicator of organic brain damage. Percept Mot Skills 8:271–276
    Santos CMC, Pimenta CAM, Nobre MRC (2007) The PICO strategy for the research question construction and evidence search. Rev Latino Am Enfermagem 15(3):508–511
    Sjøgren P (1997) Psychomotor and cognitive functioning in cancer patients. Acta Anaesthesiol Scand 41:159–161
    Sjøgren P, Banning A (1989) Pain, sedation and reaction time during long-term treatment of cancer patients with oral and epidural opioids. Pain 39:5–11. doi: 10.1016/0304-3959(89)90168-1
    Sjøgren P, Banning A, Christensen CB, Pedersen O (1994) Continuous reaction time after single dose, long-term oral and epidural opioid administration. Eur J Anaesthesiol 11:95–100
    Sjøgren P, Olsen AK, Thomsen AB, Dalberg J (2000) Neuropsychological performance in cancer patients: the role of oral opioids, pain and performance status. Pain 86:237–245. doi: 10.1016/S0304-3959(00)00248-7
    Strömgren AS, Goldsmidt D, Groenvold M, Petersen MA, Jensen PT, Pedersen L et al (2002) Self-assessment in cancer patients referred to palliative care: a study of feasibility and symptom epidemiology. Cancer 94:512–520. doi: 10.1002/cncr.10222
    Stiefel FC, Holland JC (1991) Delirium in cancer patients. Int Psychogeriatr 3:333–336. doi: 10.1017/S1041610291000789
    Vainio A, Ollila J, Matikainen E, Rosenberg P, Kalso E (1995) Driving ability in cancer patients receiving long-term morphine analgesia. Lancet 346:667–670. doi: 10.1016/S0140-6736(95)92281-4
    Vardy J, Rourke S, Tannock IF (2007) Evaluation of cognitive function associated with chemotherapy: a review of published studies and recommendations for future research. J Clin Oncol 25:2455–2463. doi: 10.1200/JCO.2006.08.1604
    Ventafridda V, Ripamonti C, DeConno F, Tamburini M, Cassileth BR (1990) Symptom prevalence and control during cancer patients last days of life. J Palliat Care 6:7–11
    Wefel JS, Lenzi R, Theriault RL, Davis RN, Meyers CA (2004) The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial. Cancer 100(11):2292–2299. doi: 10.1002/cncr.20272
    Wilson B, Cockburn J, Baddeley A (1985) The Rivermead behavioural memory test. Thames Valley Test, Titchfield
    Wood MM, Ashby MA, Somogyi AA, Fleming BG (1998) Neuropsychological and pharmacokinetic assessment of hospice inpatients receiving morphine. J Pain Symptom Manage 16:112–120. doi: 10.1016/S0885-3924(98)00043-8
    World Health Organization (2007) WHO’s pain relieve ladder. . Accessed 12 December 2007
    Zacny JP (1995) A review of the effects of opioids on psychomotor and cognitive functioning in humans. Exp Clin Psychopharmacol 3(4):432–466. doi: 10.1037/1064-1297.3.4.432